Security Features Not Limited to Paper


By Neil Versel

July 29, 2008 | Digital HealthCare & Productivity | Electronic prescribers who want to print prescriptions for Medicaid patients no longer will have to spend up to 10 times the cost of plain paper to comply with new tamper-resistance regulations, the result of intense negotiations between government officials, medical societies, the pharmacy industry, paper manufacturers, and two health-IT advocacy groups.

The Centers for Medicare and Medicaid Services (CMS) last week updated its guidance for rules that take full effect Oct. 1. Starting on that date, paper fee-for-service Medicaid prescriptions must have security features to prevent unauthorized copying, modification, and counterfeiting of prescription forms. But prescribers printing from electronic health records (EHR) or ePrescribing software may generate security features from laser or inkjet printers instead of buying pricey tamper-resistant paper.

“This defines tamper resistance by functionality, not paper,” says Peter Basch, M.D., medical director for ambulatory clinical systems at MedStar Health (Columbia, Md.) Basch, as co-chair of the Physicians’ Electronic Health Records Coalition (PEHRC) pushed for the change during a June 26 forum convened by the National Council for Prescription Drug Programs (NCPDP), a standards-development organization for pharmacy services.

According to Basch, PEHRC and the HIMSS Electronic Health Records Vendors Association convinced CMS and the NCPDP that the technology exists to produce microprinting and “void” pantographs on plain paper with off-the shelf printers. A small Canadian company called AdlerTech International has a patent for pantographs on laser and inkjet printers, and some Hewlett-Packard models can print fonts as small as 0.5 points—just six pixels high.

“Inkjet ink will smear, so that’s a safety feature, too,” Basch adds. Additionally, Basch notes, EHR and ePrescribing software can generate unique numbers for each prescription, in theory making computer-generated prescriptions more difficult to counterfeit than security paper with embossed serial numbers.

The NCPDP details the changes in a letter to state Medicaid directors. Although the correspondence is dated July 18, copies did not go out until CMS revised its guidance last week.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.